Antibodies for Coronavirus Research

The recent pandemic has caused a global effort to rapidly characterize SARS-CoV-2, the virus responsible for COVID-19, as well as develop potential treatments for the disease and create a vaccine to halt viral transmission. This substantial effort requires the right tools, resources, and support to make progress. Bio-Techne is a leader in the life science industry and offers workflow solutions for SARS-CoV-2 and COVID-19 research. A large part of our offerings includes R&D Systems highly validated and specific antibodies. Our antibodies are being used for several areas of SARS-CoV-2 research including investigation of viral recognition and characterization of the immune response following SARS-CoV-2 infection.

Explore our antibodies and related resources to find the rights tools to support and accelerate your Coronavirus research. For more information on all of Bio-Techne’s products for investigating SARS-CoV-2, including immunoassays, small molecules, cell culture products, and more, visit our Tools for Coronavirus page.


Antibodies for Detecting SARS-CoV-2

Ending the COVID-19 pandemic and controlling the spread of SARS-CoV-2 infection requires having diagnostic tools that can accurately detect the virus, as well as therapies that can treat COVID-19, and perhaps, prevent viral infection. To help develop these tools, R&D systems offers antibodies that can be used for a variety of applications including identifying those cells susceptible to SARS-CoV-2 infection or assessing assay performance during development.

Learn More About Our Antibodies for SARS-CoV-2 Detection


Antibodies for Investigating Viral Recognition by SARS-CoV-2

A key mechanism of SARS-CoV-2 infection is the binding of the coronavirus to the cell surface receptor ACE-2. This important step in viral recognition is a major target for therapeutic development. R&D Systems offers antibodies directed against virus and host cell molecules involved in viral infection, such as ACE-2 and SARS-CoV-2 proteins, that can be used to characterize protein expression or as a control for assessing the effectiveness of newly developed therapeutics.

Learn More About Our Antibodies for Viral Recognition


Antibodies for Flow Cytometry Workflows for COVID-19 Research

While huge advances have been made in understanding SARS-CoV-2 and COVID-19, there is still more that needs to be uncovered in order to successfully treat this disease and prevent future infections. Flow cytometry analysis is a powerful tool that can help advance COVID-19 research. R&D Systems offers highly specific antibodies validated for flow cytometry that can be used for protein detection and flow cytometry-based blocking assays.

Learn More About Flow Cytometry Workflows for COVID-19 Research


Antibodies for Characterizing SARS-CoV-2-Induced Immune Responses

The immunopathogenesis of SARS-CoV-2 infection continues to be a major focus of COVID-19 research as defining the contributions of immune responses in COVID-19 disease progression and severity is necessary to advance the development of therapies that regulate dysfunctional immune responses. R&D Systems offers antibodies for characterizing immune responses induced by SARS-CoV-2 infection.

Learn More About Our Antibodies for Characterizing Immune Responses


Key SARS-CoV-2 Citations Utilizing R&D Systems Antibodies

Since publication of the pivotal papers at the beginning of 2020 by Zhou, J. et al.and Hoffmann, M. et al., which used our ACE-2 antibody to show that SARS-CoV-2 uses this cell surface receptor to infect cells, our antibodies have been used in a broad range of COVID-19 research. Explore these key SARS-CoV-2 and COVID-19 related citations to see how our antibodies are being used to advance COVID-19 research. 


Additional Resources for Coronavirus Research

On-Demand COVID-19-Related Webinars

COVID-19 Symposium: Research Tools from Bio-Techne

This webinar discusses the broad range of tools Bio-Techne has developed to help researchers investigate COVID-19. Learn how our proteins, antibodies, small molecules, and other product lines, such as RNAscope® and automated protein analysis platforms can help propel your research.

Watch COVID-19 Symposium Webinar

Monitoring the Interaction of SARS-CoV-2 with ACE-2 and the Resulting Immune Response with Flow Cytometry

This webinar describes the utility of flow cytometry to investigate the interaction of SARS-CoV-2 with ACE-2 on the host cell. Learn how our flow cytometry-validated antibodies can be used for ACE-2 detection and in an in vitro flow cytometry-based ACE-2/SARS-Cov-2 blocking assay.

Watch SARS-CoV-2 with ACE-2 Interaction Webinar



ACE-2: The Receptor for SARS-CoV-2

This article reviews the seminal papers that were published at the beginning of the COVID-19 pandemic that uncovered how SARS-CoV-2 infects host cells

Read ACE-2 Receptor Article


Other Bio-Techne Resources

Novus Biologicals’ Tools for COVID-19 Research

Proteins for Coronavirus Research

Profile the Cytokine Storm with R&D Systems Immunoassays

Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO Kit powered by R&D Systems

Additional Products for SARS-CoV-2 Research and Detection